West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 346,200 | 241,700 | 206,900 | 150,700 | 143,600 |
| Depreciation Amortization | 109,100 | 103,400 | 104,400 | 96,700 | 90,700 |
| Income taxes - deferred | -5,800 | 15,300 | 900 | 41,700 | 21,500 |
| Accounts receivable | -46,600 | -33,300 | -43,800 | -39,700 | -23,300 |
| Accounts payable and accrued liabilities | 36,600 | 25,300 | 400 | 12,600 | 6,100 |
| Other Working Capital | -10,300 | -14,400 | -28,300 | -41,400 | -58,700 |
| Other Operating Activity | 43,300 | 29,200 | 48,100 | 42,700 | 39,500 |
| Operating Cash Flow | $472,500 | $367,200 | $288,600 | $263,300 | $219,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -174,400 | -126,400 | -104,700 | -130,800 | -170,200 |
| Net Acquisitions | N/A | -18,900 | N/A | -6,000 | N/A |
| Purchase Of Investment | N/A | -85,100 | 0 | 0 | -8,400 |
| Other Investing Activity | -5,100 | 2,400 | 3,900 | 3,200 | 2,800 |
| Investing Cash Flow | $-179,500 | $-228,000 | $-100,800 | $-133,600 | $-175,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 198,500 | 0 | 0 | N/A |
| Debt Repayment | -2,300 | -136,400 | -100 | -34,900 | -69,800 |
| Common Stock Issued | 34,700 | 32,700 | 32,300 | 40,100 | 29,700 |
| Common Stock Repurchased | -121,400 | -85,300 | -70,800 | -74,400 | -55,900 |
| Dividend Paid | -48,100 | -45,100 | -42,100 | -39,100 | -35,800 |
| Other Financing Activity | 0 | -1,200 | 0 | -700 | 17,900 |
| Financing Cash Flow | $-137,100 | $-36,800 | $-80,700 | $-109,000 | $-113,900 |
| Exchange Rate Effect | 20,500 | -700 | -5,600 | 12,200 | -1,300 |
| Beginning Cash Position | 439,100 | 337,400 | 235,900 | 203,000 | 274,600 |
| End Cash Position | 615,500 | 439,100 | 337,400 | 235,900 | 203,000 |
| Net Cash Flow | $176,400 | $101,700 | $101,500 | $32,900 | $-71,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 472,500 | 367,200 | 288,600 | 263,300 | 219,400 |
| Capital Expenditure | -174,400 | -126,400 | -104,700 | -130,800 | -170,200 |
| Free Cash Flow | 298,100 | 240,800 | 183,900 | 132,500 | 49,200 |